Improved survival with simendan after experimental myocardial infarction in rats
- 1 May 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 419 (2-3) , 243-248
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarctionJACC, 1999
- Dose-ranging and safety with intravenous levosimendan in low-output heart failure: experience in three pilot studies and outline of the levosimendan infusion versus dobutamine (LIDO) trialThe American Journal of Cardiology, 1999
- Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarctionJACC, 1999
- Early angiotensin converting enzyme inhibitor therapy after experimental myocardial infarction prevents left ventricular dilation by reducing infarct expansionCoronary Artery Disease, 1998
- EMD 57033 Enhances Arrhythmias Associated with Increased Wall-Stress in the Working Rat HeartClinical Science, 1995
- Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor TrialsJAMA, 1995
- Attenuation of left ventricular dilatation after acute myocardial infarction by early initiation of enalapril therapyThe American Journal of Cardiology, 1993
- Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental AnimalsJournal of Cardiovascular Pharmacology, 1983
- Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function.Circulation Research, 1981
- Physiologic basis of vasodilator therapy for heart failureThe American Journal of Medicine, 1981